Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Longatto-Filho A et al. - This is the most extensive analysis of EGFR, PDGFRA and VEGFR-2 in cervical adenosquamous carcinomas. Despite the absence of EGFR and PDGFRA activating mutations, the presence of overexpression of these three important therapeutic targets in a subset of cases may be important in predicting the sensitivity of adenosquamous carcinoma to specific anti-RTKs drugs.

Related Articles

Adenosquamous carcinoma of the sigmoid colon treated by the less invasive procedures of endoscopy and laparoscopy: Report of a case
Surgery Today, 11/12/09    Relevance Score: 66%%

Adenosquamous carcinoma of maxillary sinus: case showing complete response to S-1
The Journal of Laryngology & Otology, 11/06/09    Relevance Score: 66%%

Expression of metalloproteases and their inhibitors in different histological types of breast cancer
Journal of Cancer Research & Clinical Oncology, 11/24/09    Relevance Score: 46%%

Superficially invasive transitional cell carcinoma of the bladder associated with distant cutaneous metastases
Journal of Cutaneous Pathology, 11/18/09    Relevance Score: 46%%

Spread of Squamous Cell Carcinoma From the Thumb to the Small Finger via the Flexor Tendon Sheaths
The Journal of Hand Surgery, 11/16/09    Relevance Score: 45%%

Today in Gynecologic Oncology...keeping you current

Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/04/09

Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer
Cancer Treatment Reviews, 12/04/09

Vaginal Schwannoma in a case with uterine myoma
Annals of Diagnostic Pathology, 12/04/09